据CTV News 5月17日报道,加拿大曼尼托巴省47岁男子 Francesco Colosimo 在2025年5月突发癫痫后,被诊断患上极具侵袭性的胶质母细胞瘤(glioblastoma),这是一种男性中最常见的原发性脑肿瘤。
“药物和治疗方案对大脑伤害非常大,”Colosimo 回忆道,“那段经历太可怕了。”他的语言能力一度严重退化,到 2025 年 10 月只能依靠轮椅行动。到了年底,医生甚至告知他只剩三到六个月的生命。 面对生死关头,Colosimo 的妻子 ...
(RTTNews) - Novocure (NVCR) an oncology company, has received approval from the FDA for its new Head Flexible Electrode transducer arrays, designed for use with its Optune Gio device, which is used in ...
(RTTNews) - Novocure (NVCR) announced the FDA approved new Head Flexible Electrode transducer arrays for use with Optune Gio for the treatment of adult patients with glioblastoma multiforme. Novocure ...
ROOT, Switzerland--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) announced today that the U.S. Food and Drug Administration (FDA) approved its new Head Flexible Electrode (HFE) transducer arrays for use ...
Add Yahoo as a preferred source to see more of our stories on Google. Chico Colosimo says 'it's been a blessing' to have more time with his wife and children after a glioblastoma diagnosis last year. ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Novocure今日宣布,美国FDA已批准Optune Pax联合吉西他滨(gemcitabine)和白蛋白结合型紫杉醇(nab-paclitaxel)用于治疗局部晚期胰腺癌成人患者。根据新闻稿,这是近30年来首个获得FDA批准用于局部晚期胰腺癌的新疗法。Optune Pax是一种可穿戴医疗设备,通过递送肿瘤 ...
2026年2月,美国FDA宣布批准瑞士肿瘤物理治疗巨头Novocure(纳斯达克代码:NVCR)开发的肿瘤治疗电场装置Optune Pax用于联合吉西他滨和白蛋白结合型紫杉醇,治疗成人局部晚期胰腺癌(LA-PAC)。 这是近30年来,FDA批准的首个针对局部晚期胰腺癌的创新疗法。并且 ...
Quarterly net revenues of $174 million, up 12% year-over-year, driven by global growth in Optune Gio Optune Pax approved by the U.S. FDA and launched for the treatment of locally advanced pancreatic ...
(1) Optune Lua includes both active patients in NSCLC and MPM. Worldwide, there were 39 and 32 active MPM patients on therapy as of September 30, 2025 and 2024 and 100 and 1 active NSCLC patient(s) on ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...